Skip to main content
    H

    HealthEquity Inc (HQY)

    Official site

    HEALTHCARE • HEALTH INFORMATION SERVICES • NASDAQ

    $104.58
    +1.12 (+1.08%)

    Market Cap: $8.56B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    HealthEquity Inc (HQY) Earnings: Report Dates and Results

    Updated Aug 27, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    HealthEquity (HQY) is confirmed to report earnings on Dec 1, 2026, after the close. In the quarter ended Jul 31, 2026, HealthEquity reported EPS of $1.04, above the $0.99 estimate. It beat the EPS estimate in 7 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    85%(33/39)
    Avg Surprise
    +15.27%
    Streak
    6 Q

    Upcoming Estimates

    Reports Dec 1, 2026 after closePeriod ending Oct 31, 2026
    EPS Consensus$1.15
    Range$1.13 - $1.19
    14 analysts
    EPS Revisions
    1
    0
    30d
    EPS Estimate DriftChange to current
    90d ago$1.15-0.1%
    60d ago$1.15-0.1%
    30d ago$1.15+0.1%
    7d ago$1.15+0.1%
    Current$1.15
    Revenue Consensus
    $347.26M
    Range$344.90M - $350.05M
    14 analysts
    Reports Mar 15, 2027 (est.)Period ending Jan 31, 2027
    EPS Consensus$1.11
    Range$1.03 - $1.22
    16 analysts
    Revenue Consensus
    $367.56M
    Range$352.31M - $385.13M
    15 analysts

    Next Report

    HQY has a confirmed report date of Dec 1, 2026, after the close. Analysts' consensus for the quarter ended Oct 31, 2026 is 13.9% above the $1.01 reported for the quarter ended Oct 31, 2025.

    HQY Earnings Call

    The latest HQY earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 40 quarters below that had an estimate, HQY beat 33, missed 3 and matched 4. Revenue for the quarter ended Jul 31, 2026 was $350.73M, up 7.6% from $325.83M a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jul 31, 2026$1.04$0.99N/A+5.05%Beat-3.7%142 up, 1 downAug 27, 2026$350.73M
    Apr 30, 2026$1.07$0.94N/A+13.83%Beat+10.3%153 up, 4 downMay 28, 2026$354.64M
    Jan 31, 2026$0.95$0.90$0.86 - $0.95+5.77%Beat+37.7%150 up, 1 downMar 17, 2026$334.59M
    Oct 31, 2025$1.01$0.91$0.85 - $0.98+10.99%Beat+29.5%141 up, 1 downDec 3, 2025$322.16M
    Jul 31, 2025$1.08$0.92$0.86 - $1.00+17.39%Beat+25.6%120 up, 1 downSep 2, 2025$325.83M
    Apr 30, 2025$0.97$0.81$0.75 - $0.90+19.75%Beat+21.2%130 up, 8 downJun 3, 2025$330.84M
    Jan 31, 2025$0.69$0.72$0.68 - $0.75-4.17%Miss+9.5%133 up, 6 downMar 18, 2025$311.82M
    Oct 31, 2024$0.78$0.72$0.69 - $0.80+8.33%Beat+30.0%131 up, 0 downDec 9, 2024$300.43M
    Jul 31, 2024$0.86$0.70$0.64 - $0.75+22.86%Beat+62.3%130 up, 0 downSep 3, 2024$299.93M
    Apr 30, 2024$0.80$0.65$0.63 - $0.74+23.08%Beat+60.0%120 up, 0 downJun 3, 2024$287.60M
    Jan 31, 2024$0.63$0.56$0.49 - $0.61+12.50%Beat+70.3%114 up, 0 downMar 19, 2024$262.39M
    Oct 31, 2023$0.60$0.50$0.47 - $0.54+20.00%Beat+57.9%111 up, 0 downDec 5, 2023$249.22M
    Jul 31, 2023$0.53$0.48$0.45 - $0.51+10.42%Beat+60.6%120 up, 1 downSep 5, 2023$243.55M
    Apr 30, 2023$0.50$0.41$0.34 - $0.44+21.95%Beat+85.2%120 up, 0 downJun 5, 2023$244.43M
    Jan 31, 2023$0.37$0.35$0.32 - $0.38+5.71%Beat+85.0%122 up, 0 downMar 21, 2023$233.84M
    Oct 31, 2022$0.38$0.35$0.32 - $0.37+8.57%Beat+8.6%141 up, 0 downDec 6, 2022$216.09M
    Jul 31, 2022$0.33$0.33$0.26 - $0.360.00%In line-17.5%110 up, 0 downSep 6, 2022$206.14M
    Apr 30, 2022$0.27$0.26$0.20 - $0.31+3.85%Beat-28.9%81 up, 0 downJun 6, 2022$205.68M
    Jan 31, 2022$0.20$0.22$0.19 - $0.29-9.09%Miss-52.4%103 up, 1 downMar 22, 2022$203.30M
    Oct 31, 2021$0.35$0.35$0.32 - $0.490.00%In line-14.6%131 up, 6 downDec 6, 2021$179.95M
    Jul 31, 2021$0.40$0.36$0.32 - $0.48+11.11%Beat-4.8%13N/ASep 8, 2021$189.10M
    Apr 30, 2021$0.38$0.32$0.28 - $0.39+18.75%Beat-11.6%12N/AJun 7, 2021$184.20M
    Jan 31, 2021$0.42$0.40$0.29 - $0.44+5.00%Beat+7.7%13N/AMar 15, 2021$188.17M
    Oct 31, 2020$0.41$0.36$0.31 - $0.41+13.89%Beat-12.8%14N/ADec 7, 2020$179.35M
    Jul 31, 2020$0.42$0.28$0.25 - $0.30+50.00%Beat-6.7%13N/ASep 8, 2020$176.04M
    Apr 30, 2020$0.43$0.44$0.33 - $0.50-2.27%Miss+4.9%13N/AJun 2, 2020$190.01M
    Jan 31, 2020$0.39$0.36$0.21 - $0.43+8.33%Beat+44.4%11N/AMar 16, 2020$201.20M
    Oct 31, 2019$0.47$0.23$0.15 - $0.26+104.35%Beat+67.9%5N/ADec 3, 2019$157.12M
    Jul 31, 2019$0.45$0.35$0.32 - $0.36+28.57%Beat+32.4%10N/ASep 3, 2019$86.62M
    Apr 30, 2019$0.41$0.34$0.32 - $0.35+20.59%Beat+32.3%9N/AJun 4, 2019$87.05M
    Jan 31, 2019$0.27$0.22$0.16 - $0.25+22.73%Beat+145.5%11N/AMar 18, 2019$75.78M
    Oct 31, 2018$0.28$0.25$0.23 - $0.28+12.00%Beat+64.7%11N/ADec 4, 2018$70.50M
    Jul 31, 2018$0.34$0.28$0.25 - $0.30+21.43%Beat+61.9%12N/ASep 4, 2018$71.07M
    Apr 30, 2018$0.31$0.28$0.25 - $0.29+10.71%Beat+63.2%11N/AJun 4, 2018$69.90M
    Jan 31, 2018$0.11$0.09$0.07 - $0.11+22.22%Beat+22.2%10N/AMar 19, 2018$60.44M
    Oct 31, 2017$0.17$0.16N/A+6.25%Beat+41.7%10N/ADec 5, 2017$56.79M
    Jul 31, 2017$0.21$0.18$0.12 - $0.19+16.67%Beat+31.2%10N/ASep 5, 2017$56.88M
    Apr 30, 2017$0.19$0.19N/A0.00%In line+26.7%10N/AJun 6, 2017$55.42M
    Jan 31, 2017$0.09$0.07N/A+28.57%Beat+28.6%N/AN/AMar 21, 2017$46.81M
    Oct 31, 2016$0.12$0.12N/A0.00%In line+71.4%N/AN/ADec 6, 2016$43.36M
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Jan 31, 2026 was $4.01, up 28.1% from the year before. It was $0.52 for the year ended Jan 31, 2017, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Jan 31, 2026$4.01+28.1%
    Jan 31, 2025$3.13+38.5%
    Jan 31, 2024$2.26+67.4%
    Jan 31, 2023$1.35N/A
    Jan 31, 2022$1.33-20.8%
    Jan 31, 2021$1.68N/A
    Jan 31, 2020$1.72+43.3%
    Jan 31, 2019$1.20+76.5%
    Jan 31, 2018$0.68+30.8%
    Jan 31, 2017$0.52N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 9,000 words across 17 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,98917
    2026Q2Jun 30, 20269,07717
    2026Q1Mar 31, 20268,88416
    2025Q4Dec 31, 20255,94815
    2025Q3Sep 30, 20258,24017
    2025Q2Jun 30, 20257,00916
    2025Q1Mar 31, 20256,93715
    2024Q4Dec 31, 20249,21014

    2026Q3 Earnings Call

    Opening remarks

    Richard Putnam Head of Investor Relations Thank you, Dave. Hello, everyone. Thank you for joining us this afternoon. This is HealthEquity's third quarter fiscal year 2026 earnings conference call. My name is Richard Putnam. I do investor relations for HealthEquity. Joining me today are Scott Cutler, President and CEO; Dr. Steve Neeleman, Vice Chair and Founder of the company; and James Lucania, Executive Vice President and CFO. Before I turn the call over to Scott for prepared remarks, we note that a press release announcing our third quarter financial results was issued after the market closed this afternoon. It included certain non-GAAP financial measures that we will reference here today. You can find a copy of today's press release, including reconciliation of these non-GAAP measures with comparable GAAP measures on our Investor Relations website, which is ir.healthequity.com. We also note that our comments and responses today reflect management's views as of today, December 3, 2025, and will contain forward-looking statements as defined by the SEC, including predictions, expectations, estimates, or other information that might be considered forward-looking. There are many important factors relating to our business which could affect our forward-looking statements. These forward-looking statements are subject to risks and uncertainties that may cause our actual results to differ materially from statements made here today. We caution against placing undue reliance on these forward-looking statements. We also encourage you to review the discussion of these factors and other risks that may affect our future results or the market price of our stock, as detailed in our latest annual report on Form 10-K and in subsequent periodic reports filed with the SEC. We assume no obligation to revise or update these forward-looking statements in light of new information or future events. With that out of the way, let's go to Scott.

    Scott Cutler President and CEO Thank you, Richard. Happy holidays, and welcome, everyone. I'll start with the key metrics that reflect our continued strong fiscal 2026 results and the progress we're making on our strategy. Steve will then speak to the regulatory environment, and Jim will walk through our third quarter financials and our raised outlook for fiscal year 2026. The team again delivered strong year-over-year growth and margin expansion across our key metrics in Q3, including revenue up 7%, net income up 806% year over year, a result that Jim will explain in more detail in a moment. Adjusted EBITDA up 20% driven by gross margin of 71% and adjusted EBITDA margin of 40%. HSAs grew 6%. CDB accounts up 3%, driving total accounts up 5%, and HSA assets up 15%. Behind these numbers is a clear strategy. Helping our members better save, spend, and invest for health and strengthening the flywheel in each of those areas.

    Frequently Asked Questions About HQY

    When is HealthEquity's next earnings date?

    HealthEquity's next earnings report is confirmed for Dec 1, 2026, after the close.

    Did HQY beat earnings estimates last quarter?

    Yes. HealthEquity reported EPS of $1.04 for the quarter ended Jul 31, 2026, above the $0.99 estimate, a 5.05% surprise.

    What EPS do analysts expect from HQY next quarter?

    The consensus EPS estimate for HealthEquity for the quarter ended Oct 31, 2026 is $1.15 from 14 analysts, with estimates from $1.13 to $1.19.

    How often does HQY beat earnings estimates?

    HealthEquity beat the EPS estimate in 7 of the last 8 quarters, with an average surprise of +9.62%.

    Does HQY report before or after the market opens?

    HealthEquity is confirmed to report on Dec 1, 2026, after the market closes.